Skip to main content
. 2020 Dec 2;45(2):493–500. doi: 10.3892/or.2020.7878

Figure 2.

Figure 2.

(A) Efficacy of drugs on different cancer cells in vitro by SRB assay. Cells exposed to Bs/CUS, rE/CUS, CUS, 7D12-9G8, and CUS + 7D12-9G8 for 72 and 120 h. (B) The apoptotic activity of Bs/CUS in HepG2 cells, and results of quantitative analysis (C) ***P<0.001, ****P<0.0001 vs. control.